Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians| keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers| case reports and review articles. Publication topics include RNAi approaches| drug resistance| hematopoietic progenitor cell gene transfer| cancer stem cells| cellular therapies| homologous recombination| ribozyme technology| antisense technology| tumor immunotherapy and tumor suppressors| translational research| cancer therapy| gene delivery systems (viral and non-viral)| anti-gene therapy (antisense| siRNA & ribozymes)| apoptosis; mechanisms and therapies| vaccine development| immunology and immunotherapy| DNA synthesis and repair. Cancer Gene Therapy publishes the results of laboratory investigations| preclinical studies| and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity| gene therapy| cellular therapy| tumor suppressor and anti-oncogene therapy| cytokine/tumor immunotherapy| etc.; industry perspectives; and letters to the editor.
数据整理自公开网络的投稿反馈，仅供参考。
